NasdaqGM:LGNDPharmaceuticals
Is It Too Late To Reassess Ligand Pharmaceuticals (LGND) After A 115% One-Year Rally?
If you are wondering whether Ligand Pharmaceuticals at US$248.24 still offers value after a strong run, the next sections will break down what the current share price may be implying.
The stock has delivered returns of 5.9% over the last week, 12.6% over the last month, 30.6% year to date and 115.1% over the past year, which has put valuation firmly in focus for many investors.
Recent coverage has highlighted Ligand Pharmaceuticals in the context of its business model of acquiring and...


